Volume 17, Number 7—July 2011
Research
Hansen Disease among Micronesian and Marshallese Persons Living in the United States
Table 1
Hansen disease in residents of Micronesian and Marshallese origin, United States*
| Population group |
No. (%) patients |
Median time from US entry to report, y (range) |
MDT,†
no. (%) |
Complications, no. cases |
||||||||
| Total |
MB |
F |
Age <15 y |
ENL |
RR |
Hand/foot neuropathy |
Eye |
Other |
Any
(%)‡ |
|||
| Hawaii-residing Micronesians, 2000–2009§ | 29 | 22 (76) | 5 (17) | 3 (10) | 1.5 (0–13) | NA | NA | NA | NA | NA | NA | NA |
| Hawaii-residing Marshallese, 2000–2009§ | 43 | 31 (72) | 17 (39) | 1 (2) | 1 (0–14) | NA | NA | NA | NA | NA | NA | NA |
| US Mainland Micronesians, 1990–2009 | 55 | 42 (76) | 10 (18) | 6 (10) | 3 (0–10) | 10 (42) | 15 | 3 | 8 | 6 | 3¶ | 25 (77) |
| US Mainland Marshallese, 1990–2009 | 33 | 25 (76) | 11 (33) | 3 (10) | 2 (0–12) | 7 (32) | 6 | 3 | 5 | 1 | 1# | 12 (75) |
| Arkansas-residing Marshallese, 1990–2009 | 17 | 15 (88) | 5 (30) | 0 (0) | 2 (0–5) | 3 (20) | 4 | 2 | 2 | 0 | 0 | 12 (70) |
*Data from National Hansen’s Disease Program surveillance and clinical records, January 1990–October 2009. MB, multibacillary; MDT, multidrug therapy; ENL, erythema nodosum leprosum; RR, reversal reaction; NA, data not available.
†MDT completed, excluding patients currently under active treatment.
‡Patients for whom clinical data were available.
§Pre-2000 data were not reported to National Hansen’s Disease Program.
¶1 renal, 1 testicular, 1 palatal.
#1 renal.


